dc.contributor.author |
Halkiotis, KN |
en |
dc.contributor.author |
Uzunoglu, NK |
en |
dc.contributor.author |
Loukas, S |
en |
dc.contributor.author |
Pantelias, GE |
en |
dc.contributor.author |
Trafalis, D |
en |
dc.contributor.author |
Yova, D |
en |
dc.date.accessioned |
2014-03-01T02:48:33Z |
|
dc.date.available |
2014-03-01T02:48:33Z |
|
dc.date.issued |
1997 |
en |
dc.identifier.issn |
0277786X |
en |
dc.identifier.uri |
https://dspace.lib.ntua.gr/xmlui/handle/123456789/33887 |
|
dc.subject |
Diode laser |
en |
dc.subject |
Pancreatic cancer cells |
en |
dc.subject |
PDT |
en |
dc.subject |
Zinc tetrasulfonated phthalocyanines |
en |
dc.subject.other |
Cell culture |
en |
dc.subject.other |
Chemotherapy |
en |
dc.subject.other |
Drug therapy |
en |
dc.subject.other |
Irradiation |
en |
dc.subject.other |
Lasers |
en |
dc.subject.other |
Light |
en |
dc.subject.other |
Light sources |
en |
dc.subject.other |
Lighting |
en |
dc.subject.other |
Optical materials |
en |
dc.subject.other |
Photosensitizers |
en |
dc.subject.other |
Plasmons |
en |
dc.subject.other |
Zinc |
en |
dc.subject.other |
Cell lines |
en |
dc.subject.other |
Diode laser |
en |
dc.subject.other |
Diode lasers |
en |
dc.subject.other |
Illumination sources |
en |
dc.subject.other |
Laser lights |
en |
dc.subject.other |
Pancreatic cancer cells |
en |
dc.subject.other |
Pancreatic cancers |
en |
dc.subject.other |
PDT |
en |
dc.subject.other |
Tetrasulfonated phthalocyanines |
en |
dc.subject.other |
Treatment modalities |
en |
dc.subject.other |
Photodynamic therapy |
en |
dc.title |
Influence of drug and light dose in determining PDT efficacy in human pancreatic cancer cells, treated with zinc tetrasulfonated phthalocyanines (ZnTSPc) |
en |
heal.type |
conferenceItem |
en |
heal.identifier.primary |
10.1117/12.297811 |
en |
heal.identifier.secondary |
http://dx.doi.org/10.1117/12.297811 |
en |
heal.publicationDate |
1997 |
en |
heal.abstract |
Photodynamic Therapy (PDT) has the potential to be applied as an adjuvant treatment modality in advanced cancer cases and recently its role in the management of pancreatic cancer, has been evaluated. Nevertheless PDT remains an experimental therapy and one of the main reasons is its complexity, as far as it relies on the combined action of the photosensitising drug and light source. In this study was evaluated the effect of various photosensitizer and photoirradiation doses, in the lethality of MIA PaCa cell line by using ZnPcS4 as photosensitizer and a novel diode laser system as illumination source. No lethality was observed when only laser light or only photosensitizer was applied to cells. Cells treated with various concentrations of ZnTSPc and a light dose of 9 J/cm2 indicated more than 70% lethality, 24 hrs after irradiation and with a light dose of 6 J/cm2 presented almost 90% lethality, 72 hrs after irradiation. The results show that low light and photosensitizer (drug) doses are enough to obtain lethality of more than 90% of MIA PaCa cells. |
en |
heal.journalName |
Proceedings of SPIE - The International Society for Optical Engineering |
en |
dc.identifier.doi |
10.1117/12.297811 |
en |
dc.identifier.volume |
3191 |
en |
dc.identifier.spage |
243 |
en |
dc.identifier.epage |
252 |
en |